HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hikaru Sugimoto Selected Research

Transcription Factors (Transcription Factor)

1/2021Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hikaru Sugimoto Research Topics

Disease

27Neoplasms (Cancer)
11/2023 - 04/2003
8Fibrosis (Cirrhosis)
09/2015 - 07/2007
6Pancreatic Neoplasms (Pancreatic Cancer)
03/2023 - 11/2015
6Neoplasm Metastasis (Metastasis)
12/2018 - 09/2011
5Kidney Diseases (Kidney Disease)
01/2021 - 08/2002
5Inflammation (Inflammations)
01/2018 - 07/2007
5Proteinuria
04/2007 - 11/2002
4Hereditary Nephritis (Alport Syndrome)
06/2024 - 04/2005
4Carcinoma (Carcinomatosis)
01/2022 - 12/2006
4Pre-Eclampsia (Preeclampsia)
11/2018 - 04/2003
3Adenocarcinoma
01/2022 - 11/2015
3Renal Insufficiency (Renal Failure)
06/2021 - 07/2005
3Breast Neoplasms (Breast Cancer)
01/2020 - 11/2014
3Hypoxia (Hypoxemia)
01/2020 - 10/2005
3Carcinogenesis
10/2018 - 06/2011
3Diabetic Nephropathies (Diabetic Nephropathy)
12/2008 - 09/2002
2Insulin Resistance
04/2024 - 11/2023
2Type 2 Diabetes Mellitus (MODY)
04/2024 - 11/2023
2Hypertension (High Blood Pressure)
08/2022 - 11/2018
2IgA Vasculitis (Purpura, Schoenlein Henoch)
06/2021 - 01/2021
2Nephritis
06/2021 - 11/2002
2Diabetes Complications
01/2011 - 07/2007
2Leukemia
02/2009 - 02/2005
2Glomerulonephritis
03/2008 - 11/2002
1Glucose Intolerance
11/2023
1Pancreatitis
03/2023
1Cognitive Dysfunction
01/2023
1Dementia (Dementias)
01/2023
1Wounds and Injuries (Trauma)
01/2022
1Osteogenesis Imperfecta (Lobstein Disease)
12/2021
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2021
1Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
01/2021

Drug/Important Bio-Agent (IBA)

7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2011 - 04/2003
7type IV collagen alpha3 chain (Goodpasture antigen)IBA
06/2011 - 04/2003
6CollagenIBA
01/2022 - 06/2003
6Proteins (Proteins, Gene)FDA Link
05/2014 - 04/2003
6Collagen Type IV (Type IV Collagen)IBA
11/2009 - 04/2005
5Collagen Type I (Type I Collagen)IBA
01/2022 - 12/2006
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2022 - 06/2008
4IntegrinsIBA
01/2022 - 06/2003
4EndostatinsIBA
06/2011 - 04/2003
4Angiogenesis InhibitorsIBA
06/2011 - 03/2004
4acetoxycycloheximideIBA
02/2009 - 02/2005
3Glucose (Dextrose)FDA LinkGeneric
04/2024 - 01/2020
3RNA (Ribonucleic Acid)IBA
11/2023 - 01/2022
3Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
11/2018 - 02/2005
3Transforming Growth Factors (Transforming Growth Factor)IBA
10/2018 - 06/2010
3AntibodiesIBA
02/2013 - 04/2003
3Peptides (Polypeptides)IBA
02/2012 - 09/2008
3Streptozocin (Streptozotocin)FDA Link
01/2011 - 07/2007
2Insulin (Novolin)FDA Link
04/2024 - 11/2023
2Biomarkers (Surrogate Marker)IBA
01/2023 - 02/2013
2Indicators and Reagents (Reagents)IBA
08/2022 - 12/2018
2Adrenal Cortex Hormones (Corticosteroids)IBA
06/2021 - 01/2021
2Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
11/2018 - 06/2008
2Small Interfering RNA (siRNA)IBA
01/2018 - 01/2017
2Angiopoietin-2IBA
12/2016 - 02/2015
2GemcitabineFDA Link
11/2015 - 06/2014
2Protein Synthesis InhibitorsIBA
02/2009 - 06/2008
2Caspase 8 (Caspase-8)IBA
02/2009 - 04/2008
2Integrin alpha1IBA
11/2008 - 10/2005
2Integrin alphaVbeta3IBA
09/2008 - 02/2005
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2008 - 04/2003
2NF-kappa B (NF-kB)IBA
06/2008 - 04/2008
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2008 - 04/2008
2nephrinIBA
04/2007 - 04/2003
2Thrombospondin 1IBA
02/2005 - 03/2004
2Matrix Metalloproteinases (MMPs)IBA
03/2004 - 06/2003
1Sodium-Glucose Transporter 2 InhibitorsIBA
04/2024
1dapagliflozinIBA
04/2024
1Glucagon (Glukagon)FDA Link
04/2024
1Blood Glucose (Blood Sugar)IBA
11/2023
1Death Domain ReceptorsIBA
11/2023
1AntigensIBA
03/2023
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
03/2023
1KRASG12D inhibitor MRTX1133IBA
02/2023
1InterleukinsIBA
12/2022
1Small Nuclear RNA (snRNA)IBA
12/2022
1Estrogen ReceptorsIBA
12/2022
1Antihypertensive Agents (Antihypertensives)IBA
08/2022
1Anti-Bacterial Agents (Antibiotics)IBA
01/2022
1alpha2 Subunit Collagen Type IIBA
01/2022
1Azathioprine (Imuran)FDA LinkGeneric
06/2021
1SteroidsIBA
06/2021
1Immunoglobulin A (IgA)IBA
01/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1Antisense OligonucleotidesIBA
01/2021
1mizoribineIBA
01/2021
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2021
1Oxygen (Dioxygen)IBA
01/2020
1Pyruvic Acid (Pyruvate)IBA
01/2020
1Lactic Acid (Lactate)FDA LinkGeneric
01/2020
1Fatty Acids (Saturated Fatty Acids)IBA
01/2020
1GlycogenIBA
11/2018
1Prostaglandins FIBA
11/2018

Therapy/Procedure

12Therapeutics
06/2024 - 11/2002
2Immunotherapy
03/2023 - 06/2014
2Drug Therapy (Chemotherapy)
12/2016 - 11/2015
2Transplantation
11/2009 - 05/2006
1Brain-Computer Interfaces
01/2023